AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Clinical trial NCT06137144 · RECRUITING

Trial details

NCT number: NCT06137144
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma Non-Hodgkin Lymphoma Hodgkin Lymphoma Peripheral T-cell Lymphoma (PTCL)PTCL-NOS ALCL AITL

Start date: 2024-01-23
Primary completion: 2029-05-03
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.